Positive proof of concept of AIN457, an antibody against interleukin-17A, in relapsing-remitting multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2012
This article has no abstract
Epistemonikos ID: 1c3896bc937e6bc978bca456c9e95a8d989ec9e5
First added on: Feb 15, 2022